$BSEM SEC Filings

Filed On	Filing
13 Oct 2026	PROSPECTUS
09 Oct 2026	EFFECT
09 Oct 2026	Form 4: Smith-van Vurst Andrew, Director Received 250,000 shares by exercise or conversion ($500K)
09 Oct 2026	Form 4: Matuszewski Jason, Director Received 250,000 shares by exercise or conversion ($500K)
09 Oct 2026	D
06 Oct 2026	REGISTRATION STATEMENT
02 Oct 2026	REGISTRATION STATEMENT
30 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more This Securities Purchase Agreement (this “Agreement”) is dated as of September 29, 2026, between BioStem Technologies, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, includ...
29 Sep 2026	EFFECT
29 Sep 2026	PROSPECTUS
21 Sep 2026	D
18 Sep 2026	REGISTRATION STATEMENT
18 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of September 18, 2026 (this “Agreement”), by and between Roth Principal Investments, LLC, a Delaware limited liability company (the “Investor”), and BioStem Technologies, I...
17 Sep 2026	Form 4: Matuszewski Jason, Director Received 8,469 shares by exercise or conversion · Received 16,650 shares by exercise or conversion
17 Sep 2026	Form 4: Poe Brandon, Chief Financial Officer Received 1,694 shares by exercise or conversion
17 Sep 2026	Form 4: Smith-van Vurst Andrew, Director Received 7,622 shares by exercise or conversion · Received 9,574 shares by exercise or conversion
17 Sep 2026	Form 4: Warrington Kenneth Howard Jr, Director Received 1,694 shares by exercise or conversion
17 Sep 2026	Form 4: Fortunato Michael A, Chief Accounting Officer Received 4,234 shares by exercise or conversion
11 Sep 2026	Form 4: Hassett Barry, Chief Commercial Officer Received 500 shares by exercise or conversion
28 Aug 2026	Form 4: Ungrodt Jodi, Director Received 5,647 shares by exercise or conversion

Comments